Sort by
Refine Your Search
-
the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of
-
. The fellow will have rotations in medical information, publications, scientific communications, field-based US medical science liaison and will also have the opportunity to specialize in a preferred
-
founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio's pipeline of development programs ranges from early science to
-
data, and expand their scientific knowledge to render clinical insights and contribute to meeting the needs of healthcare professionals. About Takeda Takeda is focused on creating better health for